Mpox
Mpox, previously known as monkeypox is a rare viral disease, caused by the monkeypox virus. The virus is transmitted to humans through physical contact with an infectious person, contaminated material or an infected animals. Mpox causes a painful rash, enlarged lymph nodes, sore throat, headache and muscle aches. Rash is usually the first sign of infection, followed by sore throat, fever and muscle aches.
While mpox is generally mild and most people recover fully, some people get very sick, including those who are immunocompromised, young or pregnant. Those at highest risk of exposure, like men who have sex with men, sex workers and people with HIV, are recommended to receive the mpox vaccine. Post-exposure preventative vaccination (PEPV) should also be considered for anyone categorised as a high-risk contact with someone who has mpox. In addition to vaccination, preventive measures such as avoiding contact with wild animals, practicing good hand hygiene, and using personal protective equipment when handling potentially infected animals or materials can help reduce the risk of monkeypox virus transmission.
The Benefits of Mpox Vaccination
- Prevention of Mpox: Vaccination provides protection against mpox, reducing the risk of infection and the severity of the disease.
- Reduced Disease Transmission: Vaccination helps prevent the spread of mpox within communities, particularly in areas where the disease is endemic or during outbreaks.
- Protection for High-Risk Groups: Vaccination is particularly important for individuals at high risk of exposure to the monkeypox virus, such as healthcare workers, laboratory personnel, and individuals living in or traveling to regions where mpox is endemic.
